• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中东和北非地区乳腺癌 NCCN 指南的修改和实施。

Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region.

机构信息

Department of Oncology, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia.

出版信息

J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S8-S15. doi: 10.6004/jnccn.2010.0126.

DOI:10.6004/jnccn.2010.0126
PMID:20697133
Abstract

Published data from the Middle East and North Africa (MENA) region indicate suboptimal quality of cancer care, while the World Health Organization predicts an increase in cancer cases in developing countries. Major advances in breast cancer management mandate the development of guidelines to improve the quality and efficacy of oncology practice in the MENA region. A Breast Cancer Regional Guidelines Committee was organized and activated, comprising experts from various regional cancer institutions. The multidisciplinary team included 12 medical oncologists, 3 radiation oncologists, 2 radiologists, 2 surgeons, and 1 pathologist. The committee members agreed on adapting the current NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Breast Cancer for use in the MENA region to achieve common practice standards for treating patients. The members suggested several modifications to the guidelines, especially those related to risk factor profiles. United States-based NCCN experts reviewed these recommendations before final approval. The MENA-NCCN Breast Cancer Guidelines modification process was the first initiative in the development of common practice guidelines in the region. This project may serve as a foundation for the development of evidence-based practice standards, and improve collaborative projects and initiatives.

摘要

来自中东和北非(MENA)地区的已发表数据表明,癌症治疗的质量不尽如人意,而世界卫生组织预计发展中国家的癌症病例将会增加。乳腺癌管理的重大进展要求制定指南,以提高 MENA 地区肿瘤学实践的质量和效果。成立了一个乳腺癌区域指南委员会,并使其投入运作,该委员会由来自各个区域癌症机构的专家组成。多学科团队包括 12 名肿瘤内科医生、3 名放射肿瘤学家、2 名放射科医生、2 名外科医生和 1 名病理学家。委员会成员一致同意适应当前的 NCCN 肿瘤学临床实践指南(NCCN 指南)中的乳腺癌部分,以便在 MENA 地区实现治疗患者的共同实践标准。成员们对指南提出了一些修改建议,特别是与危险因素特征相关的建议。基于美国的 NCCN 专家在最终批准前审查了这些建议。MENA-NCCN 乳腺癌指南的修改过程是该地区制定共同实践指南的首个举措。该项目可以作为制定基于证据的实践标准的基础,并促进合作项目和举措。

相似文献

1
Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region.中东和北非地区乳腺癌 NCCN 指南的修改和实施。
J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S8-S15. doi: 10.6004/jnccn.2010.0126.
2
Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region.中东和北非地区前列腺癌 NCCN 指南的修改和实施。
J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S26-8. doi: 10.6004/jnccn.2010.0121.
3
Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region.中东和北非地区非小细胞肺癌 NCCN 指南的修改和实施。
J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S16-21. doi: 10.6004/jnccn.2010.0118.
4
Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region.中东和北非地区结肠癌 NCCN 指南的修改和实施。
J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S22-5. doi: 10.6004/jnccn.2010.0120.
5
Modification and implementation of NCCN Guidelines on palliative care in the Middle East and North Africa region.中东和北非地区缓和医疗 NCCN 指南的修改和实施。
J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S41-7. doi: 10.6004/jnccn.2010.0124.
6
Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.中东和北非地区淋巴瘤 NCCN 指南的修改和实施。
J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S29-35. doi: 10.6004/jnccn.2010.0122.
7
Modification and implementation of NCCN guidelines on hepatobiliary cancers in the Middle East and North Africa region.中东和北非地区 NCCN 肝胆肿瘤指南的修改和实施。
J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S36-40. doi: 10.6004/jnccn.2010.0123.
8
The process of NCCN guidelines adaptation to the Middle East and North Africa region.NCCN 指南在中东和北非地区的适应过程。
J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S5-7. doi: 10.6004/jnccn.2010.0125.
9
Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialty.美国临床肿瘤学会成员关于乳腺癌前哨淋巴结微转移管理的调查:根据专业划分的治疗建议差异
Ann Surg Oncol. 2009 Sep;16(9):2442-9. doi: 10.1245/s10434-009-0549-7. Epub 2009 Jun 9.
10
NCCN: Breast cancer.美国国立综合癌症网络(NCCN):乳腺癌。
Cancer Control. 2001 Nov-Dec;8(6 Suppl 2):54-61.

引用本文的文献

1
Burden of breast cancer and attributable risk factors in the North Africa and Middle East region, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.1990 - 2019年北非和中东地区乳腺癌负担及可归因风险因素:全球疾病负担研究2019的系统分析
Front Oncol. 2023 Aug 1;13:1132816. doi: 10.3389/fonc.2023.1132816. eCollection 2023.
2
Expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019.利用 2019 年全球疾病负担研究扩展乳腺癌及其危险因素的护理质量指数。
Cancer Med. 2023 Jan;12(2):1729-1743. doi: 10.1002/cam4.4951. Epub 2022 Jun 30.
3
Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay-Results From the SAFIA Phase III Trial.
基于 upfront 21 基因乳腺癌复发评分检测的新辅助内分泌治疗反应-SAFIA III 期临床试验结果。
JCO Glob Oncol. 2021 Jun;7:811-819. doi: 10.1200/GO.20.00575.
4
Assessing the Quality of Clinical Practice Guidelines in the Middle East and North Africa (MENA) Region: A Systematic Review.评估中东和北非(MENA)地区临床实践指南的质量:一项系统综述。
J Multidiscip Healthc. 2021 Feb 9;14:297-309. doi: 10.2147/JMDH.S284689. eCollection 2021.
5
Nutrition in the Prevention of Breast Cancer: A Middle Eastern Perspective.营养在预防乳腺癌中的作用:中东视角
Front Public Health. 2019 Nov 8;7:316. doi: 10.3389/fpubh.2019.00316. eCollection 2019.
6
An update on the management of breast cancer in Africa.非洲乳腺癌管理的最新情况。
Infect Agent Cancer. 2017 Feb 14;12:13. doi: 10.1186/s13027-017-0124-y. eCollection 2017.
7
Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.乳腺癌中雌激素和孕激素受体的免疫组织化学测定:与科特迪瓦302例患者临床病理因素的关系
BMC Cancer. 2017 Feb 7;17(1):115. doi: 10.1186/s12885-017-3105-z.
8
Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement.乳腺癌治疗期间的支持性护理:中低收入国家的资源配置。2013 年乳腺健康全球倡议共识声明。
Breast. 2013 Oct;22(5):593-605. doi: 10.1016/j.breast.2013.07.050. Epub 2013 Aug 31.
9
Prognostic value of bcl-2 expression among women with breast cancer in Libya.bcl-2表达在利比亚乳腺癌女性患者中的预后价值
Tumour Biol. 2013 Jun;34(3):1569-78. doi: 10.1007/s13277-013-0687-1. Epub 2013 Feb 16.
10
Prognostic value of proliferation markers: immunohistochemical ki-67 expression and cytometric s-phase fraction of women with breast cancer in libya.利比亚乳腺癌女性中增殖标志物的预后价值:免疫组织化学 Ki-67 表达和细胞周期分析 S 期分数。
J Cancer. 2012;3:421-31. doi: 10.7150/jca.4944. Epub 2012 Oct 1.